Edwards Lifesciences Corp

NYSE:EW 4:00:00 PM EDT

69.96

-0.15 (-0.21%)

: $70.20 +0.24 (+0.34%)

Market Cap (Intraday)	42.53B
Current PE	30.64
Forward PE	27.44
2yr Forward PE	24.29

See more stats

Estimates Current Quarter

Revenue	$1.48 Billion
Adjusted EPS	$0.59

See more estimates

10-Day MA	$70.88
50-Day MA	$77.35
200-Day MA	$81.45

See more pivots

Edwards Lifesciences Corp Stock, NYSE:EW

1 Edwards Way, Irvine, California 92614

United States of America

Phone: +1.949.250.2500

Number of Employees: 17300

http://www.edwards.com

Description

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.